Precision Oncology CONNECT

Expert insights on recent advances in precision oncology and future implications 🎓 New educational programme! 🎓 Medical oncologist Prof. David S. Hong, MD highlights the importance of molecular profiling to ensure patients receive the most appropriate targeted therapy to improve outcomes. 🧬 Prof. Hong also discusses two new, emerging targets, as well as two established biomarker targets and their recent clinical data. Watch the video below 📺 Download the accompanying slide set: https://lnkd.in/gY9wsEgg This educational programme is supported by an Independent Educational Grant from Bayer. #MedicalEducation #Oncology

Tissue remains the gold standard for biomarker analysis, offering critical prognostic and predictive insights to guide treatment decisions. In this downloadable infographic, endorsed by the Association for Molecular Pathology (AMP), Dr. Alexander Wyatt (GU cancer genomics) and Prof. Frédéric Bibeau (pathology) share best practices to ensure tissue samples meet quality and quantity standards for accurate biomarker testing Download here: https://ow.ly/pFhR50UkMcl #MedEd #MedicalEducation #FreeMedEd #IndependentMedEd #PrescisionMedicine #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.

Molecular profiling is vital for identifying targetable alterations, with three essential phases: pre-analytical, analytical, and post-analytical. Download this infographic, endorsed by the Association for Molecular Pathology (AMP), where Dr. Alexander Wyatt (GU cancer genomics) and Prof. Frédéric Bibeau (pathology) outline best practices to ensure tissue samples meet the quality and quantity standards needed for accurate biomarker testing. Download here: https://ow.ly/b5zO50UogHw #MedEd #MedicalEducation #FreeMedEd #IndependentMedEd #PrescisionMedicine #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.

🚨 NEW animated video series to aid your biomarker-based decision-making for gastric cancer. Precision medicine starts with high-quality samples and selecting the right biomarkers. Key techniques like IHC and ISH, and markers such as HER2, PD-L1, and MMR, are pivotal for guiding treatment. Join pathologist Prof. Frédéric Bibeau, for part-2 of this series as he shares actionable tips to optimize genomic testing in gastric cancer. Watch the video in full here: https://ow.ly/MRY450UoLIX This programme is endorsed by Association for Molecular Pathology (AMP) and supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics. #PrecisionMedicine #BiomarkerTesting #OncologyEducation

Targeted therapies are available for BRAF-mutated CRC, making early testing crucial, ideally with next-generation sequencing. 🎙️ In this podcast episode, Prof. Sebastian Stintzing and Dr Thomas Winder delve into the impact of BRAF mutations in CRC. They explore essential topics, including diagnostic testing strategies and the latest treatment options for affected patients. 🎧 Tune in to gain insights from leading experts on the evolving landscape of GI oncology here: https://ow.ly/IGh850UlbQG 📢 Endorsed by Digestive Cancers Europe #MedEd #IndependentMedEd #Oncology #GIOncology #PrecisionMedicine This educational program is supported by an Independent Educational Grant from Pierre Fabre and is intended for HCPs outside of the UK.

When it comes to precision medicine in gastric cancer, ensuring enough high-quality samples for comprehensive testing, and selecting the right biomarkers is crucial to guiding treatment decisions. Currently, IHC and ISH are the most prominent techniques for gastric precision medicine, with HER2 status, PD-L1, and MMR playing pivotal roles in treatment decision making. 🎥 In this 2-part animated video series, pathologist Prof. Frédéric Bibeau, shares actionable tips to optimise genomic testing. Watch the video in full here: https://ow.ly/97fo50Um91m This programme is endorsed by Association for Molecular Pathology (AMP) and supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics. #PrecisionMedicine #BiomarkerTesting #OncologyEducation

Best practices in the pre-analytical stage are essential for obtaining sufficient, high quality samples for biomarker testing and molecular profiling. Download this infographic, endorsed by the Association for Molecular Pathology (AMP), where Dr. Alexander Wyatt (GU cancer genomics) and Prof. Frédéric Bibeau (pathology) outline best practices to ensure tissue samples meet the quality and quantity standards needed for accurate biomarker testing. Download here: https://ow.ly/Hsge50UkMP2 #MedEd #MedicalEducation #FreeMedEd #IndependentMedEd #PrescisionMedicine #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.

Check out this poster! 🌍 International experts and patient advocates teamed up to initiate a survey on global awareness of biomarker testing among NSCLC patients and caregivers. The results are now available for you to access online! Check out the full results of this collaborative patient and caregiver survey here: https://ow.ly/RAxN50UfJ1u From COR2ED in collaboration with a panel of experts consisting of clinicians and patient advocacy group representatives; Rodrigo Paredes, Fernando Lopez-Rios, Amy Moore, Anne-Marie Baird, Shani Shilo, Christian D. Rolfo, LUNGevity Foundation, Lung Cancer Europe, and IASLC. This educational programme is supported by an Independent Educational Grant from Bayer #MedEd #MedicalEducation #PrecisionMedicine

🎥 New educational podcast! Prof. David Planchard & Dr. Federico Cappuzzo dive into the importance of BRAF mutations in metastatic NSCLC. From testing strategies (including NGS) to treatment options for 1st & 2nd lines, they explore key insights to guide clinical decisions. 💡 Key takeaways: ✅ Test all patients, regardless of histology or smoking history. ✅ Use NGS to detect targetable mutations early. ✅ Effective BRAF + MEK inhibitor combos are available with manageable safety profiles. Watch the highlights below or watch/listen in full here: https://ow.ly/FLe950Uga8V #MedicalEducation #Oncology #LungCancer #IndependentMedEd #MedEd #PrecisonMedicine This programme is supported by an Independent Education Grant from Pierre Fabre and is intended for HCPs outside the UK only.

Liquid biopsy complements tissue assays, offering key insights when combined with tissue results. Join molecular pathologist Assoc. Prof. Umberto Malapelle to learn about the emerging role of liquid biopsy in precision oncology, focusing on non-small cell lung cancer (NSCLC), breast, and colorectal cancer. Catch the full video and download the slides here: https://ow.ly/KJsp50UfGfN International Society of Liquid Biopsy endorsed. https://ow.ly/TPtY50UfGfM #MedEd #MedicalEducation #IndependentMedicalEducation #FreeMedicalEducation #Oncology #PrecisionMedicine This educational programme is supported by an Independent Medical Education Grant from Bayer.